Treatment requires selectivity to promote apoptosis only of targeted cancer cells.  Selective Photo-Apoptosis exploits the differences in light absorption of the target vs. healthy or non-targeted tissue.


Infrared light, is perceived as warmth from sources such as the sun and furnaces. Infrared light is significantly safer than ionizing radiation used for x-rays and other cancer therapies.

Selective Photo-Apoptosis uses infrared light to avoid the side effects of drugs, chemicals or ionizing radiation.  The primary side effect of infrared light is heat which is avoided by Photometics laser’s ultrashort (femtosecond) pulses.


Ultrafast (femtosecond lasers) today are either lower power, higher repetition rate fiber lasers or very unstable and finicky higher power lower repetition rate lasers.  

Photometics’ patented laser platform (Photometics EICOP Laser Platform Patent) is bringing the next generation of laser capability to medicine, aesthetics, research, education, industry and the military with both high power and low repetition rate in a rugged, stable and transportable package.